WHO denounce unequal access to vaccines worldwide

WHO denounce unequal access to vaccines worldwide

WHO, UNWTO, World Bank and IMF denounce unequal access to vaccines worldwide
The Multilateral Leaders Working Group on COVID-19 (MLT), comprised of the heads of the International Monetary Fund (IMF), World Bank, World Health Organization and World Trade Organization (UNWTO), has met with leaders from the African Vaccine Acquisition Trust (AVAT), CDC Africa, Gavi and UNICEF to address barriers to rapid vaccine scale-up in low- and middle-income countries, especially in Africa.

“Global deployment of COVID-19 vaccines is progressing at two alarming rates. Less than 2 percent of adults are fully vaccinated in most low-income countries, compared with nearly 50 percent in high-income countries,” they lamented via a statement.

These countries, most of which are in Africa, “simply cannot access enough vaccines to reach even the global targets of 10 percent coverage in all countries by September and 40 percent by the end of 2021, let alone the African Union’s target of 70 percent by 2022.”

“This crisis of vaccine inequality is causing a dangerous divergence in survival rates in COVID-19 and in the global economy. To effectively address this acute vaccine supply shortage in low- and lower-middle-income countries, and to fully enable AVAT and COVAX, the urgent cooperation of vaccine manufacturers, vaccine-producing countries, and countries that have already achieved high vaccination rates is required,” they stress.

Thank you for watching

To ensure that all countries reach the global targets of at least 10 percent coverage by September and 40 percent by the end of 2021, they call on countries that have contracted large volumes of vaccines to exchange short-term delivery schedules with COVAX and AVAT.

They also call on vaccine manufacturers to immediately prioritize and fulfill their contracts with COVAX and AVAT, and to provide regular and clear supply forecasts. They also urge the G7 and all dose-sharing countries to meet their commitments urgently, with greater visibility of production lines, product shelf life and support for ancillary supplies, as barely 10 percent of the nearly 900 million doses committed have been shipped so far.

“We call on all countries to remove export restrictions and any other trade barriers on COVID-19 vaccines and the inputs involved in their production.
In parallel, we are intensifying our work with COVAX and AVAT to address persistent vaccine supply, manufacturing and trade issues, especially in Africa, and to mobilize grants and concessional funding for these purposes. We will also explore funding mechanisms to cover future vaccine needs, as requested by AVAT. We will advocate for improved supply forecasts and investments to increase countries’ preparedness and absorptive capacity. And we will continue to improve our data, to identify gaps and improve transparency in the supply and use of all COVID-19 tools. The time to act is now. The course of the pandemic-and the health of the world-is at stake,” they stress.

SourceWHO